The introduction of counterfeit or adulterated medicines into the supply chain is a serious issue that could adversely affect the safety of prescription medicines and the health of patients. To that end, HDA strongly supports tough, rigorous and consistent standards for state licensing of pharmaceutical distributors as required under federal law.
Having strong, consistent distributor licensing is a critical component to ensuring that criminals do not infiltrate the supply chain and gain access to prescription medicines.
HDA and its member companies support uniform licensing standards that prevent the entry of unscrupulous or criminal elements, address the roles and responsibilities of distributors in the supply chain and provide accountability for their business practices. We are committed to a business model that maintains the safety and integrity of the prescription drug products that patients depend on for their health and well-being.